- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.84 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x ZN: ZINC ION(Non-covalent)
- 3 x 3EO: (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide(Non-covalent)
3EO.2: 28 residues within 4Å:- Chain A: Q.42, S.43, F.44, Y.57, H.58, G.59, V.79, D.80, D.82, V.133, L.136, K.137, G.138, S.139, S.140, F.155, R.156, A.157, A.158, C.160, D.169
- Chain C: H.111, P.132, V.133, S.134, Y.135
- Ligands: CL.10, CL.11
18 PLIP interactions:14 interactions with chain A, 4 interactions with chain C- Hydrophobic interactions: A:D.82, A:V.133, A:L.136, A:K.137, A:F.155, A:R.156, A:A.158, C:P.132, C:P.132, C:Y.135
- Hydrogen bonds: A:H.58, A:G.138, A:S.139, A:S.140, A:S.140, A:R.156, A:A.158, C:S.134
3EO.5: 26 residues within 4Å:- Chain A: P.132, V.133, S.134, Y.135, G.163
- Chain B: Q.42, S.43, F.44, Y.57, H.58, G.59, V.79, D.80, D.82, V.133, L.136, K.137, G.138, S.139, S.140, F.155, R.156, A.157, A.158, C.160, D.169
22 PLIP interactions:4 interactions with chain A, 18 interactions with chain B- Hydrophobic interactions: A:P.132, A:P.132, A:Y.135, B:Q.42, B:F.44, B:D.82, B:V.133, B:L.136, B:K.137, B:F.155, B:R.156, B:A.157, B:A.158
- Hydrogen bonds: A:S.134, B:H.58, B:D.82, B:G.138, B:S.139, B:S.140, B:S.140, B:R.156, B:A.158
3EO.9: 29 residues within 4Å:- Chain B: H.111, D.113, P.132, V.133, S.134, Y.135, G.163
- Chain C: Q.42, S.43, F.44, Y.57, H.58, G.59, V.79, D.80, D.82, V.133, L.136, K.137, G.138, S.139, S.140, F.155, R.156, A.157, A.158, C.160, D.169
- Ligands: CL.6
22 PLIP interactions:5 interactions with chain B, 17 interactions with chain C- Hydrophobic interactions: B:P.132, B:P.132, B:Y.135, C:F.44, C:D.82, C:V.133, C:L.136, C:K.137, C:F.155, C:F.155, C:R.156, C:A.158
- Hydrogen bonds: B:S.134, C:H.58, C:D.82, C:G.138, C:S.139, C:S.140, C:S.140, C:R.156, C:A.158
- pi-Stacking: B:Y.135
- 5 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.6: 3 residues within 4Å:- Chain B: S.134, K.137
- Ligands: 3EO.9
Ligand excluded by PLIPCL.7: 2 residues within 4Å:- Chain B: D.113, Y.135
Ligand excluded by PLIPCL.10: 2 residues within 4Å:- Chain C: S.134
- Ligands: 3EO.2
Ligand excluded by PLIPCL.11: 2 residues within 4Å:- Chain C: D.113
- Ligands: 3EO.2
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parsy, C. et al., Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease. Bioorg.Med.Chem.Lett. (2014)
- Release Date
- 2014-09-10
- Peptides
- NS3 protease: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CC
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.84 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x ZN: ZINC ION(Non-covalent)
- 3 x 3EO: (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide(Non-covalent)
- 5 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parsy, C. et al., Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease. Bioorg.Med.Chem.Lett. (2014)
- Release Date
- 2014-09-10
- Peptides
- NS3 protease: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CC
E